France’s Sanofi under investigation in Depakine birth defects case

French healthcare company Sanofi said it had been put under investigation over a legal case relating to Depakine, a medication known to have caused birth malfunctions and slow neurological development after being taken during pregnancy.

…read more

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News